The combination of these methods provides a novel pipeline for analysing and understanding longitudinal tau data, allowing us to compare changes in disease dynamics throughout the AD timeline and predict subject-specific, region-specific changes in tau over time. The gene discussed is MAPT; the disease is Alzheimer disease.